U.S. Healthtech Stock News

Why ONEOK’s latest earnings matter for shareholders ONEOK (OKE) recently reported fourth quarter and full year 2025 results that paired strong revenue and net income with slightly softer earnings per share, alongside fresh 2026 guidance on profits and system volumes. For investors, this combination of detailed backward looking numbers and forward looking targets offers a clearer picture of how the midstream business is performing across natural gas, natural gas liquids and refined...

Recent share performance and business profile Without a specific headline event driving trading activity today, Two Harbors Investment (TWO) has still drawn attention after a recent share price move, prompting investors to reassess its risk and income profile. The stock shows a 1 day return of around a 1% decline, with a 7 day move of about a 3% decline and a one month performance near an 11% decline, while the past 3 months sit modestly positive. Over longer periods, total returns are mixed,...

Lemonade, Inc. recently reported Q4 and full-year 2025 results, with revenue rising to US$228.1 million for the quarter and US$737.9 million for the year, while net loss and loss per share both narrowed compared with 2024. The company also recorded its first quarter of positive free cash flow since its IPO and introduced “Lemonade Autonomous Car,” an AI-driven, real-time priced insurance product for Tesla vehicles, signaling a push into autonomous-vehicle coverage. We’ll now examine how...

Why TransUnion Is On Investors’ Radar Today TransUnion (TRU) is drawing fresh attention as investors weigh its recent share performance against current fundamentals, including annual revenue of US$4.58b and net income of US$455.4m. With the stock last closing at US$78.31, recent returns over the past month and past 3 months are in focus, alongside multi year total return figures that show a mixed picture. See our latest analysis for TransUnion. The recent 9.9% 7 day share price return...

JBT Marel (JBTM), formerly John Bean Technologies Corporation, recently completed its rebranding in January 2025, drawing new attention to how its current valuation aligns with its fundamentals and recent share performance. See our latest analysis for JBT Marel. Despite a softer patch recently, with a 7 day share price return of a 5.5% decline, JBT Marel still shows a 90 day share price return of 10.3% and a 1 year total shareholder return of 19.8%. This suggests that momentum has generally...

In late February 2026, Icahn Enterprises L.P. reported fourth-quarter 2025 results showing US$2,170 million in sales, a swing to US$1 million in net income from a prior-year net loss, and confirmed a quarterly US$0.50 per depositary unit distribution payable in April 2026 with an option to receive cash or units. Beneath the headline numbers, management highlighted improved profitability, positive fund performance, and sizable cash reserves, alongside a reduced indicative net asset value...

In late February 2026, American Healthcare REIT, Inc. reported fourth-quarter and full-year 2025 results showing higher revenue of US$604.08 million for the quarter and US$2.26 billion for the year, a swing to net income of US$10.78 million for Q4 and US$69.81 million for 2025, and sharply lower real estate impairment charges. At the same time, the company launched and began using a new US$1.75 billion at-the-market common stock offering program, including forward sale flexibility, while...

If you are wondering whether Workday is starting to look interesting on price after a rough patch, you are not alone. This article is here to help you make sense of where the valuation currently sits. Workday last closed at US$134.01, with returns of 3.7% over the past 7 days, a 23.7% decline over 30 days, a 34.9% decline year to date, and a 47.4% decline over the past year that has changed how many investors think about its risk and return profile. These moves have come as investors...

In February 2026, Stable Sea announced a partnership with dLocal to power low-cost, high-speed stablecoin-based B2B cross-border payments across more than 40 countries, using dLocal’s local payout rails. This collaboration highlights how dLocal is deepening its role in emerging-market payment infrastructure by combining its local rails with stablecoin settlement for large-ticket international transactions. Next, we’ll explore how integrating stablecoin rails into its cross-border platform...

Kadant Inc. recently reported its fourth-quarter and full-year 2025 results, showing quarterly sales of US$286.2 million and flat net income of US$24.03 million, alongside essentially unchanged earnings per share versus the prior year. For 2025 as a whole, Kadant’s sales were broadly stable at about US$1.05 billion, but full-year earnings per share from continuing operations eased, while management issued 2026 guidance that points to higher expected revenue and GAAP EPS. We’ll now examine...

In late February 2026, Delek US Holdings reported fourth-quarter 2025 results showing US$2,429.4 million in sales and a US$78.3 million net profit, while also completing a buyback program that repurchased 21,331,155 shares for US$606.09 million and affirming a quarterly dividend of US$0.255 per share. This combination of a sharp earnings turnaround, cash flow initiatives such as the enterprise optimization plan, and continued capital returns through buybacks and dividends underlines...

In the past week, Archer Aviation reported fourth-quarter 2025 results showing US$0.3 million in sales and a net loss of US$188.9 million, filed a US$317.86 million shelf registration for employee stock plans, and presented at the Raymond James Institutional Investor Conference. Alongside these financial updates, Archer deepened its global air taxi ambitions through a Starlink connectivity collaboration, a new UK engineering hub in Bristol, and progress on certification programs in the US...

Olin (OLN) has come under fresh scrutiny after releasing preliminary Q4 2025 guidance that management acknowledged was weaker than earlier expectations. The company cited maintenance outages, raw material disruptions, and softer pipeline chlorine demand. See our latest analysis for Olin. Despite the softer preliminary Q4 2025 guidance, Olin’s recent share price momentum has been strong, with a 30 day share price return of 22.10% and a 90 day share price return of 19.63%, while the 3 year...

Why Nektar Therapeutics Is On Investors’ Radar Today Nektar Therapeutics (NKTR) has caught investor attention after a period where its shares showed strong moves over the past month and past 3 months, contrasting with mixed shorter term returns. See our latest analysis for Nektar Therapeutics. At a share price of $68.36, Nektar’s recent 30 day share price return of 83.12% and year to date share price return of 57.44% sit alongside a very large 1 year total shareholder return. This suggests...

Why Norfolk Southern Stock Is Getting Attention Now Norfolk Southern (NSC) is drawing fresh interest from investors after recent share price moves, with the stock’s month and past 3 months returns sitting in the high single digits and low double digits. See our latest analysis for Norfolk Southern. The recent move to a share price of US$317.47 sits alongside a 1 month share price return of 9.01% and a year to date share price return of 10.30%. The 1 year total shareholder return of 32.15% and...

In February 2026, Travelers Companies launched its AI Claim Assistant, an agentic voice solution built on OpenAI models and APIs to handle auto damage claim calls, streamline submissions, and free claim professionals to focus on more complex issues while retraining call center staff into higher-value roles. The rollout highlights how Travelers is embedding advanced analytics and AI directly into its claims workflow, blending automation with live human support to potentially raise service...

What the No.3PLUS launch could mean for Olaplex Holdings (OLPX) Olaplex Holdings (OLPX) has launched No.3PLUS Complete Repair Treatment, a pre-shampoo product built on its Bond Building Technology and new Damage Defense Cationic Complex, supported by a broad retail rollout and a science themed marketing campaign. See our latest analysis for Olaplex Holdings. Despite today’s 5.6% one day share price decline, Olaplex’s 90 day share price return of 36.9% and 12.6% year to date gain suggest...

Oshkosh Defense recently announced a public-private partnership with the Marine Depot Maintenance Command to support advanced manufacturing, materiel support, and the Digital Manufacturing Exchange, enabling secure local production of validated vehicle parts for faster military repairs and improved fleet readiness. By sharing controlled technical data to authorize local part manufacturing while protecting intellectual property, Oshkosh is embedding itself more deeply in the U.S. military’s...

KeyCorp (KEY) is in focus after analysts revisited their views following recent quarterly results. At the same time, stubborn inflation data, credit risk worries, and a pickup in insider selling are tempering sentiment around the regional bank. See our latest analysis for KeyCorp. After a strong 14.39% 90 day share price return, KeyCorp’s 1 year total shareholder return of 30.36% contrasts with a slightly negative year to date share price move. This suggests momentum has cooled as inflation...

FactSet Research Systems (FDS) is back in focus after quarterly results in which revenue surpassed analyst expectations, while full-year EPS guidance came in slightly below consensus, alongside continuing dividend payments. See our latest analysis for FactSet Research Systems. The share price tells a mixed story, with a 15.6% 7 day share price return after earnings contrasting with a 22.8% year to date share price decline and a 51.29% 1 year total shareholder return decline. This suggests...

What Huntsman’s latest earnings mean for shareholders Huntsman (HUN) recently reported fourth quarter and full year 2025 results, showing lower sales and a larger annual net loss, developments that help explain the stock’s recent moves. For the fourth quarter, Huntsman reported sales of US$1,355 million compared with US$1,452 million a year earlier. The company posted a net loss of US$96 million, compared with a net loss of US$141 million in the prior year period. Basic and diluted loss per...

Edwards Lifesciences (EW) is back in focus after the U.S. FDA cleared its SAPIEN M3 transcatheter mitral valve replacement system and the company issued 2026 sales guidance tied to product momentum and innovation. See our latest analysis for Edwards Lifesciences. The FDA approval of SAPIEN M3 and Edwards Lifesciences' 2026 sales outlook arrive as the share price trades at US$87.18, with a 7-day share price return of 5.75% and a 1-year total shareholder return of 22.12%. This suggests momentum...

Etsy (ETSY) is back in focus after a cluster of fresh catalysts, including UK pricing rule changes, its decision to sell Depop to eBay, and fourth quarter profitability that exceeded Wall Street expectations. See our latest analysis for Etsy. At a share price of $53.97, Etsy has had a mixed year, with a 10.03% one year total shareholder return contrasting with a 54.56% total shareholder return decline over three years and a 71.63% total shareholder return decline over five years. This...

Ondas (ONDS) is back in focus after committing a $10 million investment to World View Enterprises and landing multi million dollar defense deals tied to its Iron Drone system in Europe and Israel. See our latest analysis for Ondas. Those defense contracts and the World View stake come after a sharp rerating, with Ondas’ share price returning 32.22% over the past 90 days yet sitting slightly lower year to date, while the 1 year total shareholder return is extremely high, pointing to very...